Research on infections caused by bacteria and how to fight them. Covers antibiotic resistance, biofilms, congenital syphilis, Lyme disease, and precise treatments.
Researchers at Indiana University found that bacteria secrete molecules, like coelechelin, which weaken competitors' immune systems and increase their vulnerability to phage infection. This discovery highlights the potential of phage-chemical combinations in treating antibiotic-resistant infections.
Scientists have successfully created silver nanoparticles using store-bought goji berries, a process that eliminates the need for additional chemicals and is biologically compatible with humans. The nanoparticles were tested for their antimicrobial activity against Staphylococcus aureus and confirmed to be effective.
A new system can quickly identify emerging virus variants and provide information on their genetic changes, helping to understand why they spread differently in human populations. This enables the development of more effective vaccines and targeted treatments for diseases such as flu, COVID, and tuberculosis.
A new bone regeneration scaffold, Qx-D, shows promise in treating infected bone defects by exhibiting broad-spectrum antibacterial activity against various bacteria. The scaffold also supports the adhesion and differentiation of key cell types involved in bone regeneration.
Researchers at Texas A&M University have developed a skin-like material that can mimic human skin textures and elasticity, simulating conditions for bacterial growth. The Ecoflex-based skin replicas can be used to test wearable sensors and improve catheter designs, potentially reducing the risk of catheter-related bloodstream infections.
A new study finds that disease-causing bacteria can infect a wide range of plant species, including non-flowering plants, using a common set of pathogenicity factors. The research suggests that the toxin syringomycin interferes with cell membranes across diverse plant species.
Researchers created skin-like replicas using Ecoflex, a type of silicone rubber, to evaluate risks of bacterial infections from intravenous catheters. The study found that the replicas could replicate human skin roughness and elasticity, showing promise for implementing infection control measures.
Researchers found that soil contains antibiotic resistance genes that can be transmitted to humans, making it a pressing public health threat. The study reveals how these genes spread through the environment and highlights the importance of understanding soil ecosystems to control antibiotic resistance.
A recent study found a significant increase in severe multidrug-resistant Shigella sonnei infections among people experiencing homelessness (PEH) in Vancouver. The strain, genotype 3.6.1.2, is resistant to nearly all antibiotics, leading to higher hospitalization rates and more severe outcomes.
A recent study published in Nature found that mother fleas can transmit the plague to their offspring, posing a significant threat to prairie dog colonies and other rodent populations. This discovery highlights the importance of understanding the role of animals in the dissemination of the disease.
A new study finds that Enterococcus faecalis produces protective capsular slime when present with certain strains of pathogenic Escherichia coli, making E. coli more resistant in low-iron environments. This discovery could lead to the development of targeted therapies for specific dog and poultry infections.
A new study found that climate warming can increase the severity of bacterial infections in cold-blooded animals like corals, insects, and fish. The researchers analyzed data from 60 experimental studies and found that infected animals were more likely to die when exposed to higher temperatures.
Research finds that Streptococcus mutans's collagen-binding protein may induce hematuria and IgA deposition in kidney disease, suggesting a potential pathogenic role. The study suggests a link between oral pathogens and renal lesions.
Brigham researchers found that intestinal infections alter bile composition to promote intestinal defense, highlighting the liver's role in defending against infection. The study identified hundreds of new bile metabolites and revealed a shift in bile function during enteric infection.
Researchers found pandrug-resistant Klebsiella pneumoniae in Ukrainian war victims, showing high virulence and rapid spread. The bacteria's ability to cause disease remains despite antibiotic resistance.
Researchers developed an artificial intelligence model that selects the best phage cocktail for a given patient based on their genome. The model was tested on a new collection of E. coli strains responsible for pneumonia and showed high success rates.
Antimicrobial resistance is a growing threat in Detroit, requiring immediate attention from the community. Health experts recommend educating oneself about responsible antibiotic use and adopting practices such as hand hygiene and vaccination.
Two studies found that multidrug-resistant Enterobacterales, particularly Escherichia coli ST131 and Providencia stuartii NDM-1, are spreading in healthcare and community settings across Europe. The emergence of these resistant bacteria poses a significant threat to carbapenem treatment effectiveness.
Researchers have demonstrated a potential antibacterial treatment from a modified darobactin against infections caused by bacteria such as E. coli and Acinetobacter baumannii, which are known to develop drug resistance. The compound D22 showed efficacy in animal trials, highlighting its promise for further development.
A new study by the CHAMPS network reveals that meningitis contributes to higher child mortality rates than estimated by the WHO, with 7% of deaths attributed to the disease. The study also highlights the shift towards antibiotic-resistant bacteria, particularly in hospital-associated cases.
Researchers developed a nasal vaccine combining traditional pertussis antigens with an innovative adjuvant called T-vant to boost immune response. The new vaccine was shown to prevent the bacteria's colonization in the respiratory tract, significantly curbing whooping cough spread.
A new study reveals dramatic changes to gut and mouth bacteria in people with chronic liver disease, correlating with increased antibiotic resistance and poor clinical outcomes. The findings suggest a need for personalized microbiome-based treatments and rapid diagnosis of infections to improve patient care.
A new study found that zinc deficiency promotes lung infection by Acinetobacter baumannii bacteria, which is a leading cause of ventilator-associated pneumonia. Blocking IL-13 prevented infection-associated death in an animal model, suggesting anti-IL-13 antibodies may protect against bacterial pneumonia in patients with zinc deficiency.
Scientists have discovered a weakness in antibiotic-resistant bacteria that can be exploited to stop the spread of this public health crisis. By understanding the link between magnesium limitation and ribosome variants, researchers may develop novel drug-free approaches to combat antibiotic resistance.
A new UC Davis Health study has uncovered the mechanisms by which Salmonella bacteria evade the body's natural defenses in the gut. The research found that Salmonella alters the gut's nutrient environment to fuel its replication in the large intestine, creating an imbalance that helps the pathogen survive. This new understanding could ...
A $3.96 million grant will support the development of a monitoring device and data-processing algorithm to guide combination therapy design against multidrug-resistant bacteria. The goal is to overcome bacterial defenses and combat the emergence of resistance.
Researchers identified a genetic weakness in drug-resistant Mycobacterium tuberculosis, allowing them to develop targeted drugs. This technology has the potential to combat other drug-resistant pathogens and prevent their spread.
A groundbreaking metagenomic sequencing test has proven effective in rapidly diagnosing almost any kind of pathogen, including viruses, bacteria, fungus or parasite. The test analyzes all nucleic acids present in a sample, replacing multiple tests with a single one and speeding up diagnosis.
Researchers at WVU are developing a hybrid of silver and carbon nanotubes to reduce antibiotic-resistant infections in open bone fractures. The study aims to create a safe and effective antimicrobial material that can be used on various medical products.
A team of scientists at IISc has devised a way to break down biofilm barriers using an enzyme from the cow’s digestive tract, making bacteria more susceptible to antibiotics. The enzyme successfully broke down biofilms in four strains of Klebsiella pneumoniae and prevented its development altogether.
Researchers found that HNL Dimer levels decrease rapidly within a day of successful antibiotic treatment, offering a time-saving advantage over traditional biomarkers. This study confirms the previous promising results and provides valuable insights for early diagnosis and treatment of sepsis.
A new strain of antibiotic-resistant bacteria, ST164, has been spreading widely across Asia, posing significant challenges to global public health. Researchers discovered that 80.9% of A. baumannii bacteria found in patients were CRAB, with ST164 accounting for 40.2% of samples.
Researchers at Johns Hopkins Medicine have identified a potential link between donor intestinal epithelial cells and improved outcomes for patients undergoing fecal microbiota transplants. The study found that these cells, which line the intestinal tract, may be responsible for restoring gut health in some patients.
A new study published in The Lancet Child & Adolescent Health found that children living in areas with a high burden of tuberculosis have a consistently high annual risk of developing TB infection throughout childhood. By age 10, over 10% of children developed TB disease.
Researchers at Houston Methodist have identified a new strain of bacteria, Streptococcus dysgalactiae subspecies equisimilis (SDSE), linked to increasingly severe human infections. The study used integrative analysis to investigate the genome, transcriptome, and virulence of SDSE strains, shedding light on their molecular pathogenesis.
The study found that P. aeruginosa adapts to the lung's mucus by relying on sugars and lactate, but also needs to synthesize essential nutrients through metabolic independence. Biofilm formation imposes a metabolic burden, slowing down the bacteria's ability to spread, while disrupting biofilms makes them more vulnerable to antibiotics.
Researchers designed a skin patch that uses imperceptible electric currents to control microbes, stopping 99% of biofilm formation in bacteria. The device, called Bioelectronic Localized Antimicrobial Stimulation Therapy, could lead to a wearable patch with a wireless circuit to control infections without drugs.
A study by FSU researchers has found a potential link between an infection caused by gut bacteria and the progression of Alzheimer's disease. The research suggests that antibiotic exposure can lead to issues not just in the gut but also in the brain, triggering neuroinflammation and neurocognitive impairment.
Researchers developed a nanomedicine that attacks bacteria at the molecular level, reducing antibiotic resistance and side effects. The technology releases medication only when required, ensuring patients take exact amounts to fight infections.
Researchers at Aarhus University have decoded part of the bacterial defense mechanism against antibiotics, providing a crucial step towards treating resistant MRSA infections. Understanding the molecular composition of the biofilm-forming protein PSMα1 could lead to new strategies and treatments to prevent biofilm formation.
The study describes the full molecular structure of the phage DEV, which infects and lysates Pseudomonas aeruginosa bacteria. The researchers discovered a genome ejection motor that pulls the DNA out of its head after infection, with conserved design principles across all Schitoviridae phages.
Researchers have identified a new group of bacterial toxins that can destroy cells of bacteria and fungi without harming other organisms. The study reveals how these toxins are used by bacteria to compete with other microbes, offering exciting possibilities for clinical and biotechnological applications.
Researchers discovered a new species of bacteria, Hardy ecospecies, that thrives on carnivore diets, contradicting the long-held assumption that modern humans are omnivores. The study found genetic variations in bacteria that inform us about our ancestors' diet.
A team of researchers from the University of Florida Health has been awarded a significant grant to explore the use of combination antibiotics to combat antibiotic-resistant bacteria. The study aims to understand the molecular mechanisms behind bacterial resistance and develop new treatment strategies to tackle deadly superbugs.
A new study reveals that fecal microbiota transplants can increase Lachnospiraceae bacteria, which outcompete C. diff for resources and alter bile acids to create an environment favorable for other good bacteria to thrive.
A team of HKU chemists has made a breakthrough in combating antibiotic-resistant bacteria by combining bismuth-based drugs with antibiotics. This synergistic approach disrupts bacterial iron homeostasis, effectively eliminating multi-drug resistant Pseudomonas aeruginosa infections.
Scientists have found a way to pinpoint single bacteria that are resistant to antibiotics, making it easier to choose the right treatment. This breakthrough could lead to improved treatment outcomes for patients with Staphylococcus aureus infections.
A new study has identified the genetic elements responsible for transforming classical Klebsiella pneumoniae into a devastating, drug-resistant killer. Researchers found that the plasmid pVir is the primary determinant of hypervirulence in this bacterium.
A team of researchers at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. The antibodies were found to interact with antigens on the bacterial surface and some act synergistically to neutralize the pathogen.
Researchers developed a nasal spray that captures and neutralizes airborne viruses and bacteria, providing up to 8 hours of protection. The Pathogen Capture and Neutralizing Spray (PCANS) demonstrated a greater than 99.99% reduction in lung viral titers in mice models.
Researchers have developed an antibody that can identify Campylobacter jejuni and inhibit its growth, reducing pathogenicity. The antibody targets a multiprotein complex essential for the bacteria's energy production, making it a potential target for therapy and vaccination.
A proof-of-concept study introduces a medical device that measures protease activity in human breath to diagnose lower respiratory tract infections. The system showed elevated levels of human neutrophil elastase in patients with confirmed lower respiratory tract infections, suggesting its potential for rapid and non-invasive diagnosis.
Researchers at Chalmers University of Technology have developed a graphene-based, ultra-thin antibacterial material that can kill 99.9% of bacteria on surfaces, including medical devices and implants. The new technology uses fridge magnet technology to control the orientation of graphene flakes, making it possible for practical applica...
A Virginia Tech research team has identified a molecular mechanism by which Shigella flexneri bacteria manipulate host molecules to ensure their survival. The study provides a new understanding of the infection pathway and its potential implications for preventing similar infections in other bacteria.
Researchers have conducted the largest genomic survey of the syphilis bacterium to date, correlating genetic data with clinical information to identify potential targets for a vaccine. The study found differences in bacterial strains between continents, but also similarities that suggest a global vaccine could be effective.
A recent study published in Cell Reports Medicine has discovered an important immune component that offers protection against MRSA infection. The researchers found that IgM antibodies are required for clearance of S. aureus during an infection, suggesting a new direction for future vaccine strategies and therapies.
A new monoclonal antibody drug has been developed to prevent infection with A. baumannii, a common cause of hospital-acquired infections. The treatment was shown to be effective in reducing bacterial load in mice, and could potentially become a powerful new weapon against antimicrobial resistance.
Researchers will conduct laboratory and field work at UC Medical Center to detect airborne transmission of MRSA. The study aims to better understand the significance of airborne transmission of MRSA and inform enhanced workplace safety measures.
Repeated antibiotic use can cause defects in the gut's protective mucus barrier, even months after treatment. This is due to changes in the microbiota or direct effects of antibiotics on the mucus layer. The findings suggest that antibiotics should be used responsibly to prevent long-lasting damage.
Acinetobacter baumannii is a highly resistant bacterial species causing serious infections. Researchers have engineered mutant strains to study anti-Acinetobacter compounds and address AMR preparedness.